, Tracking Stock Market Picks
Enter Symbol:
Rating: DD
Buy $80
down 18.00 %

E.i. Du Pont De Nemours And Company (NYSE: DD) reiterated to Buy with price target $80 by Argus

Wednesday,  Jan 20, 2016  2:25 PM ET by Betsy O'Brien Harrison

Argus reiterated E.i. Du Pont De Nemours And Company (NYSE: DD) to Buy with price target $80. Previously Argus reiterated E.i. Du Pont De Nemours And Company (NYSE: DD)
to Buy with price target $72 on 11/02/2015, when the stock price was $64.06. Since then, E.i. Du Pont De Nemours And Company's stock price has lost 18% as of 01/20/2016's recent price of $52.35.
If you would have followed the previous Argus's recommendation on DD, you would have lost 18% of your investment in 79 days.

E.I. DuPont de Nemours is involved in science and technology in a range of disciplines including high-performance materials, specialty chemicals, pharmaceuticals and biotechnology. The company operates globally through strategic business units. Within the strategic business units, businesses manufacture and sell a wide range of products to many different markets, including the transportation, textile, construction, automotive, agricultural and hybrid seeds, nutrition and health, pharmaceuticals, packaging and electronics markets.

Argus Research is an independent research firm, and our business is producing, distributing and marketing high-quality investment and economic research. Our recommendations - BUY, HOLD and SELL - reflect the judgment of an analyst about a company's prospects as an investment in terms of value, expected growth and risks. Argus Research does not bring companies public, advise companies on mergers and acquisitions, broker trades, make markets in stocks or manage money. Our independence allows us to make critical judgments about companies that we might not be so free to make were we competing for a firm's underwriting business. Because we're not a broker/dealer, we don't have "inventory" of a stock that we have to move with a tainted recommendation. We have developed a six-point system for analyzing the stocks in our Universe of Coverage. We believe that this system

RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy